These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 19024573)

  • 21. Use of low molecular weight heparin in pregnant women with mechanical heart valves.
    Yinon Y; Siu SC; Warshafsky C; Maxwell C; McLeod A; Colman JM; Sermer M; Silversides CK
    Am J Cardiol; 2009 Nov; 104(9):1259-63. PubMed ID: 19840573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitral valve replacement and thromboembolic risk.
    Benussi S; Verzini A; Alfieri O
    J Heart Valve Dis; 2004 May; 13 Suppl 1():S81-3. PubMed ID: 15225011
    [No Abstract]   [Full Text] [Related]  

  • 23. Antithrombotic therapy following bioprosthetic aortic valve replacement.
    Nowell J; Wilton E; Markus H; Jahangiri M
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):578-85. PubMed ID: 17267235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing mechanical valves with reduced anticoagulation.
    Slaughter MS; Jweied E
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1073-85. PubMed ID: 18035923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement.
    Eitz T; Schenk S; Fritzsche D; Bairaktaris A; Wagner O; Koertke H; Koerfer R
    Ann Thorac Surg; 2008 Mar; 85(3):949-54; discussion 955. PubMed ID: 18291177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late results of valve replacement surgery. II. Complications of prosthetic heart valves.
    Murphy ES; Kloster FE
    Mod Concepts Cardiovasc Dis; 1979 Nov; 48(11):59-66. PubMed ID: 530237
    [No Abstract]   [Full Text] [Related]  

  • 27. Incidence and risk factors of early thromboembolic events after mechanical heart valve replacement in patients treated with intravenous unfractionated heparin.
    Allou N; Piednoir P; Berroëta C; Provenchère S; Ibrahim H; Baron G; Montravers P; Iung B; Philip I; Ajzenberg N
    Heart; 2009 Oct; 95(20):1694-700. PubMed ID: 19482850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulation after artificial valve replacement with or without atrial fibrillation: how much is really needed?
    Verheugt FW
    Thromb Haemost; 1999 Sep; 82 Suppl 1():130-5. PubMed ID: 10695504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early anticoagulation after mechanical valve implantation, and related complications.
    Puri D; Kumar A; Basu R; Chaudhary A; Sarwal V; Sahoo M; Mahant TS
    J Heart Valve Dis; 2008 Jul; 17(4):418-24; discussion 425. PubMed ID: 18751472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of guideline-based anticoagulation in a patient with mitral prosthetic valve and recurrent thromboembolism.
    Mutlu H; Yerlioglu ME; Levy WK
    J Am Soc Echocardiogr; 2008 Mar; 21(3):296.e1-3. PubMed ID: 17681732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Haemorrhagic and thrombo-embolic complications in patients with prosthetic valves--the under-appreciated problem with no safe solutions].
    Trzeciak P; Poloński L; Zembala M
    Kardiol Pol; 2006 Sep; 64(9):1038-42. PubMed ID: 17054041
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of thrombosis in heart valve diseases].
    Meyer BJ; Beer JH
    Ther Umsch; 1998 Dec; 55(12):756-61. PubMed ID: 10025189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anticoagulation therapy in cardiac patients with mechanical valve prostheses].
    Milosević U; Anojcić S
    Srp Arh Celok Lek; 1990; 118(11-12):481-9. PubMed ID: 2133607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioprostheses: thromboembolic events in prosthetic valves. Working Group of the European Society of Cardiology on the Evaluation of Prosthetic Valves. 15-16 December, 1983, Paris, France. Abstracts.
    Eur Heart J; 1983 Dec; 4 Suppl I():1-32. PubMed ID: 6667702
    [No Abstract]   [Full Text] [Related]  

  • 35. [Anticoagulation therapy in patients with valve defects].
    Chlumský J; Potuzník P
    Vnitr Lek; 1996 Feb; 42(2):78-81. PubMed ID: 8686194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventing thromboembolism in patients with prosthetic heart valves.
    Turpie AG
    Cardiol Clin; 1994 Aug; 12(3):487-93. PubMed ID: 7805081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recommendations for prevention of thromboembolism in heart valve diseases. Working Group on Valvular Heart Disease, European Society of Cardiology].
    Gohlke-Bärwolf C; Acar J; Oakley C; Butchart E; Burckhardt D; Delahaye JP; Horstkotte D; Bodnar E; Hall R; Kremer R
    Z Kardiol; 1995 Dec; 84(12):1018-32. PubMed ID: 8578786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of anticoagulation in patients with bioprostheses.
    Gherli T; Colli A; Nicolini F
    J Heart Valve Dis; 2004 May; 13 Suppl 1():S88-9. PubMed ID: 15225014
    [No Abstract]   [Full Text] [Related]  

  • 39. The problem of cardiac valve prostheses, anticoagulants, and pregnancy.
    Salazar E; Zajarias A; Gutierrez N; Iturbe I
    Circulation; 1984 Sep; 70(3 Pt 2):I169-77. PubMed ID: 6744561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of patients with prosthetic heart valves during non-cardiac surgery.
    Prendergast BD
    Przegl Lek; 2004; 61(6):556-9. PubMed ID: 15724633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.